| Product |
CAS |
Molecular formula |
More |
| 2,5-Dioxopyrrolidin-1-yl pyrrolidine-1-carboxylate |
1443642-86-1 |
C9H12N2O4 |
More |
| 2,5-Dioxopyrrolidin-1-yl 4-benzylpiperidine-1-carboxylate |
1443642-85-0 |
C17H20N2O4 |
More |
| 2,5-Dioxopyrrolidin-1-yl piperidine-1-carboxylate |
1443642-84-9 |
C10H14N2O4 |
More |
| 1-[[5-Chloro-2-(pyrrolidin-1-yl)phenyl]methyl]piperazine |
1446818-75-2 |
C15H22ClN3 |
More |
| Tert-butyl 4-[[5-chloro-2-(pyrrolidin-1-yl)phenyl]methyl]piperazine-1- |
1446818-74-1 |
C20H30ClN3O2 |
More |
| 1-[[2-Chloro-6-(pyrrolidin-1-yl)phenyl]methyl]piperazine |
1446818-72-9 |
C15H22ClN3 |
More |
| Tert-butyl 4-[[2-chloro-6-(pyrrolidin-1-yl)phenyl]methyl]piperazine-1- |
1446818-71-8 |
C20H30ClN3O2 |
More |
| 2-Chloro-6-(pyrrolidin-1-yl)benzaldehyde |
110405-86-2 |
C11H12ClNO |
More |
| Tert-butyl 4-(di(pyridin-3-yl)methyl)piperazine-1-carboxylate |
1446818-55-8 |
C20H26N4O2 |
More |
| Tert-butyl 4-(bis(1-methyl-1h-indazol-5-yl)methyl)piperazine-1-carboxy |
1446818-54-7 |
C26H32N6O2 |
More |
| Bis(1-methyl-1h-indazol-5-yl)methanol |
1446818-53-6 |
C17H16N4O |
More |
| 1-(Bis(4-chloro-2-methylphenyl)methyl)piperazine |
1446818-52-5 |
C19H22Cl2N2 |
More |
| Tert-butyl 4-(bis(4-chloro-2-methylphenyl)methyl)piperazine-1-carboxyl |
1446818-51-4 |
C24H30Cl2N2O2 |
More |
| Tert-butyl 4-(bis(oxazol-4-yl)methyl)piperazine-1-carboxylate |
1446818-50-3 |
C16H22N4O4 |
More |
| Tert-butyl 4-(bis(4-chlorophenyl)methyl)-3-methylpiperazine-1-carboxyl |
1446818-48-9 |
C23H28Cl2N2O2 |
More |
| Tert-butyl 4-[[4-bromo-2-(propan-2-yl)phenyl]methyl]piperazine-1-carbo |
1446819-66-4 |
C19H29BrN2O2 |
More |
| 4-([4-[(Tert-butoxy)carbonyl]piperazin-1-yl]methyl)-3-chlorobenzoic ac |
1446819-30-2 |
C17H23ClN2O4 |
More |
| N,n-dimethyl-5-phenyl-2-(piperazin-1-ylmethyl)benzamide |
1446819-61-9 |
C20H25N3O |
More |
| Tert-butyl 4-[[2-(dimethylcarbamoyl)-4-phenylphenyl]methyl]piperazine- |
1446819-60-8 |
C25H33N3O3 |
More |
| Tert-butyl 4-[[4-bromo-2-(dimethylcarbamoyl)phenyl]methyl]piperazine-1 |
1446819-59-5 |
C19H28BrN3O3 |
More |
